Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Edward A. Sausville is active.

Publication


Featured researches published by Edward A. Sausville.


Archive | 2004

Mouse Models in Cancer Drug Discovery and Development

Edward A. Sausville; Melinda G. Hollingshead

The basis for proceeding with development of an anticancer agent has historically resulted in part from the capacity of the agent to inhibit tumor cell proliferation either in tissue culture (in vitro) or in animals (in vivo), without specific reference to a molecular or cellular target of action. Indeed, the potentially useful effects of the vast majority of agents currently approved for use as safe and effective as oncologic therapeutics in humans were initially detected by their favorable performance in mouse models of human cancer. This chapter provides an overview of the types of mouse models used in cancer drug discovery and development, their strengths and limitations, how to interpret them, and caveats in the consideration of results from commonly used murine model studies. The algorithm currently in use at the National Cancer Institute (NCI) in the United States is presented. This chapter is meant to be a practical, working summary of practice rather than a comprehensive review of the topic. For the latter, the reader is encouraged to seek more encyclopedic treatments (1–3, among others).


Journal of Biological Chemistry | 1997

The Amino-terminal Domain of Heat Shock Protein 90 (hsp90) That Binds Geldanamycin Is an ATP/ADP Switch Domain That Regulates hsp90 Conformation

James P. Grenert; William P. Sullivan; Patrick Fadden; Timothy A. J. Haystead; Jenny Clark; Edward Mimnaugh; Henry Krutzsch; Hans-Joachim Ochel; Theodor W. Schulte; Edward A. Sausville; Leonard M. Neckers; David O. Toft


Archive | 2002

Geldanamycin derivative and method of treating cancer using same

Kenneth M. Snader; B. Rao Vishnuvajjala; Melinda G. Hollingshead; Edward A. Sausville


Archive | 2001

Geldanamycin derivatives useful for the treatment of cancer

Kenneth M. Snader; Leonard M. Neckers; B. Roa Vishnuvajjala; Edward A. Sausville; Wanping Xu; Meredith F. N. Rosser; Christopher V. Nicchitta; Jennifer A. Isaacs


Archive | 2002

Geldanamycin derivatives useful for treating cancer

Kenneth M. Snader; B. Rao Vishnuvajjala; Melinda G. Hollingshead; Edward A. Sausville


Archive | 2002

Geldanamycinderivate und verfahren zur krebsbehandlung unter verwendung derselben

Melinda G. Hollingshead; Edward A. Sausville; Kenneth M. Snader; B. Rao Vishnuvajjala


Archive | 2002

DERIVADO DE GELDANAMICINA UTIL PARA EL TRATAMIENTO DEL CANCER.

Melinda G. Hollingshead; Edward A. Sausville; Kenneth M. Snader; B. Rao Vishnuvajjala


Archive | 2002

Geldanamycin derivative and use of same to treat cancer

Kenneth M. Snader; B. Rao Vishnuvajjala; Melinda G. Hollingshead; Edward A. Sausville


Archive | 2002

Gelanamycinderivater suitable for the treatment of cancer

Melinda G. Hollingshead; Edward A. Sausville; B. Rao Vishnuvajjala; Kenneth M. Snader


Archive | 2002

Geldanamycin derivative useful for the treatment of cancer.

Melinda G. Hollingshead; Edward A. Sausville; Kenneth M. Snader; B. Rao Vishnuvajjala

Collaboration


Dive into the Edward A. Sausville's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jenny Clark

University of Virginia

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge